NEW YORK (GenomeWeb) – GeneNews reported today a 78 percent decrease in second quarter revenues, reflecting a drop off in sales of its ColonSentry colorectal cancer blood test and other diagnostics.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.